Juvenile nasopharyngeal angiofibroma (JNA) is a rare, benign and locally invasive tumor. Massive bleeding because of vascularity of tumor and postoperative recurrence are potential problems of management. Endonasal approach reduces the rate of postoperative recurrence, intraoperative bleeding, and complications of surgery, time of operation and duration of hospitalization. In this article, we review the indications and contraindications of endoscopic surgery, indications of radiotherapy in treatment of JNA and our policy in postoperative follow-up and management of patients.
Mohammadi Ardehali,M and Ghorbani,J . (2011). Juvenile Nasophryngeal Angiofibroma,New Aspects in Management. Iranian Journal of Otorhinolaryngology, 23(3), 61-68. doi: 10.22038/ijorl.2011.236
MLA
Mohammadi Ardehali,M , and Ghorbani,J . "Juvenile Nasophryngeal Angiofibroma,New Aspects in Management", Iranian Journal of Otorhinolaryngology, 23, 3, 2011, 61-68. doi: 10.22038/ijorl.2011.236
HARVARD
Mohammadi Ardehali M, Ghorbani J. (2011). 'Juvenile Nasophryngeal Angiofibroma,New Aspects in Management', Iranian Journal of Otorhinolaryngology, 23(3), pp. 61-68. doi: 10.22038/ijorl.2011.236
CHICAGO
M Mohammadi Ardehali and J Ghorbani, "Juvenile Nasophryngeal Angiofibroma,New Aspects in Management," Iranian Journal of Otorhinolaryngology, 23 3 (2011): 61-68, doi: 10.22038/ijorl.2011.236
VANCOUVER
Mohammadi Ardehali M, Ghorbani J. Juvenile Nasophryngeal Angiofibroma,New Aspects in Management. Iranian Journal of Otorhinolaryngology. 2011;23(3):61-68. doi: 10.22038/ijorl.2011.236
